Veloxis Pharmaceuticals A/S announced that Johnny Stilou will step down as EVP & Chief Financial Officer as part of the Company's decision to close down all Danish activities and move to the US. ohnny Stilou will remain with the Company until the end of August 2016 to secure the transition of activities to the US.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- DKK | -.--% | -.--% | -0.50% |
1st Jan change | Capi. | |
---|---|---|
-0.50% | 1.64B | |
+16.34% | 79.03B | |
+8.65% | 8.78B | |
-16.33% | 4.83B | |
+51.22% | 4.65B | |
+2.18% | 3.89B | |
+20.51% | 2.34B | |
-26.79% | 2.18B | |
+15.12% | 2.11B | |
-36.56% | 2B |
- Stock Market
- Equities
- VELO Stock
- News Veloxis Pharmaceuticals A/S
- Veloxis Pharmaceuticals A/S Announces the Step Down of Johnny Stilou as EVP & Chief Financial Officer